Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

AstraZeneca receives DCG(I) nod for Durvalumab in India

financialexpressJune 29, 2018

Tag: AstraZeneca , DCG , India

PharmaSources Customer Service